February 2012 DSM-5 Webinar

DSM-IV-TR vs. Proposed DSM-5: Comparison, Implications and Impact

Produced in partnership with The Change Companies

Archived: Click here to download this one-hour webinar for free! Earn CE credit for your time by passing the CE Quiz.

Download: PowerPoint Slides and Live Event Q&A

Price: Education is FREE to all professionals

Earn Continuing Education Credit: All applicants for CE credit are required to complete and pass this online CE Quiz after viewing the presentation. Members of NAADAC or AccuCare Subscribers receive a Certificate of Completion for 1 CE for free. Non-members of NAADAC or Non-subscribers of AccuCare receive 1 CE for $15 (make payment here). A CE certificate will be emailed to you within 21 days of submission and receiving payment, if applicable. Click here for a complete list of who accepts NAADAC Continuing Education Credit.

Description: The proposed DSM‐5 will eliminate the words “abuse” and “dependence” from the diagnostic lexicon and replace them with a dimensional perspective with “moderate” and “severe.” The proposed changes will also delete legal problems related to use and replace it with the construct of a compulsion to use. All 11 of the new criteria will be on a continuum. Those with positive findings on two or three of the 11 will receive a diagnosis of “moderate substance use disorder” and those with four or more positive findings will receive a diagnosis of “severe substance use disorder.”

This presentation will utilize diagnostic information on a sample of more than 7,000 adults from a structured interview that captures elements of both diagnostic formulations. We will examine the similarities and differences under the proposed DSM‐5 for alcohol, cannabis and cocaine diagnoses. For some groups, the new diagnoses will place the same people into a comparable diagnostic group. However, for those with a current diagnosis of abuse, substantial changes in diagnoses will be noted. Clinical and policy implications will be discussed.

Learning Objectives:

As a result of participating in this webinar, you will be able to:

describe the proposed DSM‐5 criteria and how it differs from the current DSM‐IV‐TR;
explain why some with a current diagnosis of abuse will not receive a diagnosis with the new criteria;
identify which diagnostic orphans (those with dependence indications but no diagnosis) will get a diagnosis in the new criteria;
discuss the similarities and differences based on the substance under consideration;
discuss the clinical and policy implications for DUI/DWI offenders.

Presenter:

Dr. Norman G. Hoffmann is a clinical psychologist who has evaluated behavioral health programs and provided consultations for over 35 years. He has worked with private organizations and governmental agencies in a variety of countries. Dr. Hoffmann served on an accreditation panel for the British Home Office and currently does accreditation reviews for the European Addiction Treatment Association. He has developed a variety of assessments instruments used throughout the United States, as well as in Canada, Sweden, Norway, and the United Kingdom. He has also designed student surveys to assess needs and evaluate prevention impacts. Dr. Hoffmann is the author of more than 150 publications and has held faculty appointments at the University of Texas Medical Branch, University of Minnesota and Brown University. Currently he is President of Evince Clinical Assessments and adjunct professor of psychology at Western Carolina University.

Who Should Attend:
Addiction professionals, employee assistance professionals, social workers, mental health counselors, professional counselors, psychologists andother helping professionals that are interested in learning about addiction-related matters.

Questions or comments about NAADAC Education? Email This e-mail address is being protected from spambots. You need JavaScript enabled to view it

This presentation is for individual use only and may not be reproduced without permission from NAADAC.